Skip to content

Supplier News

McLane to buy foodservice wholesaler

McLane Co. plans to acquire Meadowbrook Meat Co. (MBM), a national foodservice distributor. Financial terms of the deal weren’t disclosed. McLane chief executive officer Grady Rosier stated Thursday that the acquisition expands McLane’s portfolio of companies in the food and beverage industries.

Taro nixes Sun Pharma buyout bid

Taro Pharmaceutical Industries Ltd. has given a thumbs-down to an unsolicited buyout proposal by Sun Pharmaceutical Industries Ltd. Taro said Thursday that a special committee of its board unanimously rejected the Oct.

Par Pharma to be sold to TPG

Par Pharmaceutical Cos. has agreed to be acquired by private equity firm TPG in a deal valued at $1.9 billion. The generic drug and specialty pharmaceutical company said Monday that under the agreement, Par can solicit proposals from other parties until Aug. 24, and its board plans to do so. If

GSK to buy Human Genome Sciences

GlaxoSmithKline plans to acquire Human Genome Sciences (HGS) in a cash deal of about $3 billion. GSK said Monday that the purchase of HGS will give the company full ownership of the medications Benlysta (lupus), albiglutide (type 2 diabetes) and darapladib (coronary heart disease).

Par Formulations lands first ANDA approval

Par Formulations Private Ltd., a subsidary of Par Pharmaceutical Cos., has received its first Abbreviated New Drug Application (ANDA) approval from the Food and Drug Administration. The company said Friday that Par Formulations, formerly Edict Pharmaceuticals Private Ltd.